Skip to main content

and
  1. No Access

    Article

    Serplulimab Plus Chemotherapy vs Chemotherapy for Treatment of US and Chinese Patients with Extensive-Stage Small-Cell Lung Cancer: A Cost-Effectiveness Analysis to Inform Drug Pricing

    Serplulimab is a potential valuable therapy, while patients, physicians, and decision-makers are uncertain about the cost-effectiveness of this novel drug and its corresponding reasonable price. This study aim...

    Taihang Shao, Mingye Zhao, Leyi Liang, Wenxi Tang in BioDrugs (2023)